Ann: Positive Safety Data from Third Cohort of PI Clinical Trial, page-20

First 20 Last

Share
Profile

Follow
BelowAverage

779 Posts.

125

09/02/22

01:48

Post #: 59444522
Share

Originally posted by lonade: ↑

we are seeing the same play typical play as it happens everywhere with junior biotech.

we are now at a stage, where people with a higher risk profile (or have been able to reduce the risk...) have fully invested following sufficient DD that gives them the knowledge to understand the high chances of success.
the constant safety trial news just strengthens the notion that we have made the right choice. but we only add in small amounts, since we already have a large part of our targeted shares. hence, not really impacting the share price anymore.

the others simply don't have the guts and / or brains to take the decision to buy now or start buying yet. they are lurking around and hoping that it does not rise too much...some of those will be posting negatives to try to bring it down again, to compensate their lack of brains / guts with manipulating others instead.

its like the same old story when people keep asking you how you made so much money: you need to be able to take the difficult decisions when the majority is hesitant and make the first steps when everybody is backing down. few do it and jealousy eats them up....

biotech is a patience game with incomparable rewards should they succeed.

Expand

That makes sense, great points.

P.S we now know what the additional lettering on the upcoming trials meant.

RCE Price at posting: $1.26 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

LML

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

QGL

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

WML

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

TNC

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

There are more pages in this discussion • 18 more messages in this thread...

First 20 Last

Add RCE (ASX) to my watchlist

(20min delay)
Last 54.0¢		Change 0.000(0.00%)		Mkt cap ! $125.2M

Open	High	Low	Value	Volume
54.0¢	54.0¢	52.0¢	$1.969K	3.714K

Buyers (Bids)

No.	Vol.	Price($)
1	341	52.0¢

Sellers (Offers)

Price($)	Vol.	No.
54.0¢	49936	1

View Market Depth

No.	Vol.	Price($)
1	341	0.520
2	4128	0.515
4	90651	0.510
2	55942	0.505
3	45000	0.500

Price($)	Vol.	No.
0.540	49936	1
0.550	17052	3
0.555	24068	2
0.565	5000	1
0.570	54708	3

Last trade - 16.10pm 14/10/2024 (20 minute delay)

RCE (ASX) Chart

Ann: Positive Safety Data from Third Cohort of PI Clinical Trial, page-20

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Positive Safety Data from Third Cohort of PI Clinical Trial, page-20

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News